Sally A. Beard
163 Studley Rd
Heidelberg, VIC 3084, Australia
Heidelberg, VIC 3084, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
Kampo Medicines Modulate Angiogenic, Antioxidant, and Inflammatory Pathways in Human Preclinical Models: Implications for Preeclampsia.
Journal: Antioxidants (Basel, Switzerland)
Published: June 08, 2026
Brain and C-type natriuretic peptide are expressed by the human placenta and are not altered with preeclampsia, fetal growth restriction, or placental hypoxia.
Journal: Placenta
Published: December 14, 2025
High-throughput drug screening identifies EGFR/MAPK pathway targeting sensitivities in organoid models of ovarian carcinosarcoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: September 10, 2025
Evaluating valaciclovir, letermovir, and maribavir safety in first-trimester human placental development.
Journal: Scientific reports
Published: August 20, 2025
Investigating the Impact of Maternal Obesity on Disease Severity in a Mouse Model of Preeclampsia.
Journal: Nutrients
Published: April 01, 2025
Amniotic Fluid Extracellular Vesicle Properties Evolve With Gestational Age and Reflect Fetal Development.
Journal: Journal of extracellular biology
Published: March 17, 2025
Phosphoglucomutase 5 gene transcripts are expressed by the human placenta and differentially regulated in placental dysfunction.
Journal: Scientific reports
Published: October 22, 2024
Exploring the Therapeutic Potential of C-Type Natriuretic Peptide for Preeclampsia.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: July 17, 2024
Investigating ticagrelor in a preclinical pipeline as a novel therapeutic to prevent preterm birth.
Journal: Reproduction (Cambridge, England)
Published: October 18, 2023
Last Updated: 09/26/2026